EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY-NC 4.0

A Comparison of Systematic, Targeted, and Combined Biopsy Using Machine Learning for Prediction of Prostate Cancer Risk: A Multi-Center Study

Mostafa A Arafa, Islam Omar, Karim H Farhat, Mona Elshinawy, Farrukh Khan, Faisal A Alkhathami, Alaa Mokhtar, Abdulaziz Althunayan, Danny M Rabah, Abdel-Hameed A Badawy

Medical Principles and Practice · 2024

DOI: 10.1159/000540425 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Medical Principles and Practice, 2024. Verfasst von Mostafa A Arafa und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Cancer Research Chair, Surgery Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Machine Learning, Prostate-Specific Antigen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aims of the study were to construct a new prognostic prediction model for detecting prostate cancer (PCa) patients using machine-learning (ML) techniques and to compare those models across systematic and target biopsy detection techniques.

Methods

The records of the two main hospitals in Riyadh, Saudi Arabia, were analyzed for data on diagnosed PCa from 2019 to 2023. Four ML algorithms were utilized for the prediction and classification of PCa.

Results

A total of 528 patients with prostate-specific antigen (PSA) greater than 3.5 ng/mL who had undergone transrectal ultrasound-guided prostate biopsy were evaluated. The total number of confirmed PCa cases was 234. Age, prostate volume, PSA, body mass index (BMI), multiparametric magnetic resonance imaging (mpMRI) score, number of regions of interest detected in MRI, and the diameter of the largest size lesion were significantly associated with PCa. Random Forest (RF) and XGBoost (XGB) (ML algorithms) accurately predicted PCa. Yet, their performance for classification and prediction of PCa was higher and more accurate for cases detected by targeted and combined biopsy (systematic and targeted together) compared to systematic biopsy alone. F1, the area under the curve (AUC), and the accuracy of XGB and RF models for targeted biopsy and combined biopsy ranged from 0.94 to 0.97 compared to the AUC of systematic biopsy for RF and XGB algorithms, respectively.

Conclusions

The RF model generated and presented an excellent prediction capability for the risk of PCa detected by targeted and combined biopsy compared to systematic biopsy alone. ML models can prevent missed PCa diagnoses by serving as a screening tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMachine LearningProstate-Specific AntigenHumansMaleMiddle AgedAgedSaudi ArabiaImage-Guided BiopsyAlgorithmsMultiparametric Magnetic Resonance ImagingRisk AssessmentRetrospective StudiesProstate

Stichwörter der Autor:innen

Machine learningProstate cancer riskSystematic biopsyTargeted biopsy

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • The Cancer Research Chair, Surgery Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
  • Klipsch School of Electrical and Computer Engineering, New Mexico State University, Las Cruces, New Mexico, USA.
  • Engineering Technology and Surveying Engineering Department, New Mexico State University, Las Cruces, New Mexico, USA.
  • Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Department of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Zitieren

APA

Arafa, M. A., Omar, I., Farhat, K. H., Elshinawy, M., Khan, F., Alkhathami, F. A., Mokhtar, A., Althunayan, A., Rabah, D. M., & Badawy, A. A. (2024). A Comparison of Systematic, Targeted, and Combined Biopsy Using Machine Learning for Prediction of Prostate Cancer Risk: A Multi-Center Study. Medical Principles and Practice. https://doi.org/10.1159/000540425

Vancouver

Arafa MA, Omar I, Farhat KH, Elshinawy M, Khan F, Alkhathami FA, et al. A Comparison of Systematic, Targeted, and Combined Biopsy Using Machine Learning for Prediction of Prostate Cancer Risk: A Multi-Center Study. Medical Principles and Practice. 2024. doi:10.1159/000540425

BibTeX
@article{Arafa2024,
  author = {Arafa, Mostafa A and Omar, Islam and Farhat, Karim H and Elshinawy, Mona and Khan, Farrukh and Alkhathami, Faisal A and Mokhtar, Alaa and Althunayan, Abdulaziz and Rabah, Danny M and Badawy, Abdel-Hameed A},
  title = {A Comparison of Systematic, Targeted, and Combined Biopsy Using Machine Learning for Prediction of Prostate Cancer Risk: A Multi-Center Study},
  journal = {Medical Principles and Practice},
  year = {2024},
  doi = {10.1159/000540425}
}
Kostenlos starten →